Target intelligence / Profile preview

Immunoglobulin (Ig) (Ig)

Target
Ig
Molecular classification
Plasma protein, Glycoprotein, Antibody
01

Overview

Gamma globulins are a major class of serum proteins, predominantly consisting of immunoglobulins (antibodies) such as IgG, IgA, and IgM, which are critical components of the adaptive immune system (StatPearls, 2023). Produced by plasma cells, these proteins recognize and bind to specific antigens on pathogens, facilitating their neutralization or destruction through mechanisms like opsonization and complement activation (Britannica, 2024). In clinical practice, gamma globulin preparations, such as intravenous immunoglobulin (IVIG), are administered as replacement therapy for primary immunodeficiency or as immunomodulators for autoimmune conditions like immune thrombocytopenia (ITP) (Mayo Clinic, 2023). Furthermore, specific immunoglobulins or the pathways regulating their persistence, such as the neonatal Fc receptor (FcRn), have become significant therapeutic targets. Drugs like FcRn inhibitors (e.g., efgartigimod) are designed to lower the levels of pathogenic IgG autoantibodies in diseases such as myasthenia gravis by preventing their recycling and promoting degradation (Nature Reviews Drug Discovery, 2022). Monitoring gamma globulin levels via serum protein electrophoresis or specific assays is essential for diagnosing plasma cell dyscrasias and assessing the efficacy of B-cell depleting or FcRn-targeting therapies (NCBI, 2022).

Other names
Gamma globulinAntibodyImmune globulinSerum globulin
02

Mechanism of action

Neonatal Fc receptor (FcRn) antagonism to increase IgG catabolism (Nature Reviews Drug Discovery, 2022); direct neutralization of circulating IgE to prevent allergic cascades (PubMed, 2023); and passive immunization through exogenous administration (StatPearls, 2023).

03

Biological functions

Immune responseAntigen neutralizationComplement activationOpsonization
04

Disease associations

InfectionAutoimmune diseaseImmunodeficiencyInflammationAllergy
05

Safety considerations

Increased susceptibility to infectionsInfusion-related reactionsHypogammaglobulinemiaThrombotic events
06

Interacting drugs

Efgartigimod alfa

4 more in the full profile.

07

Biomarkers

Serum IgG levelsSerum IgE levelsSpecific autoantibody titersSerum protein electrophoresis (SPEP)

Beyond the preview

Go deeper on Immunoglobulin (Ig) (Ig).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin (Ig) (Ig).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call